Delayed onset of the diurnal melatonin rise in patients with Huntington's disease

Journal of Neurology

Volumn 256, Issue 12, 2009, Pages 1961-1965

  Aziz, N Ahmad ^a   Pijl, Hanno ^a   Frölich, Marijke ^a   Schröder Van Der Elst, Janny P ^a   Van Der Bent, Chris ^a   Roelfsema, Ferdinand ^a   Roos, Raymund A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Circadian rhythm; Huntington's disease; Hypothalamus; Melatonin; Sleep

Indexed keywords

MELATONIN; PAROXETINE;

BLOOD SAMPLING; BODY MASS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FUNCTIONAL DISEASE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUNTINGTON CHOREA; MALE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; REVIEW; SLEEP;

CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MELATONIN; MIDDLE AGED; SLEEP DISORDERS; TIME FACTORS;

EID: 71849115710     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5196-1     Document Type: Review

References (25)

1. I Arnulf J Nielsen E Lohmann J Schieffer E Wild P Jennum, et al. 2008 Rapid eye movement sleep disturbances in Huntington disease Arch Neurol 65 4 482 488 10.1001/archneur.65.4.482 10.1001/archneur.65.4.482 18413470 (Pubitemid 351549956)
2. A Aziz R Fronczek M Maat-Schieman U Unmehopa F Roelandse S Overeem, et al. 2008 Hypocretin and melanin-concentrating hormone in patients with Huntington disease Brain Pathol 18 4 474 483 1:CAS:528:DC%2BD1cXht1CjtLrP 18498421
3. NA Aziz H Pijl M Frolich AW van der Graaf F Roelfsema RA Roos 2009 Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease J Clin Endocrinol Metab 94 4 1223 1228 10.1210/jc.2008-2543 1:CAS:528: DC%2BD1MXksFaitLs%3D 19174491
4. Bates G, Harper PS, Jones L (2002) Huntington's disease, 3rd edn. Oxford University Press, New York
5. EE Benarroch 2008 Suprachiasmatic nucleus and melatonin: reciprocal interactions and clinical correlations Neurology 71 8 594 598 10.1212/01.wnl.0000324283.57261.37 10.1212/01.wnl.0000324283.57261.37 18711114
6. J Cabrera RJ Reiter DX Tan W Qi RM Sainz JC Mayo, et al. 2000 Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings Neuropharmacology 39 3 507 514 10.1016/S0028-3908(99)00128-8 10.1016/S0028-3908(99)00128-8 1:CAS:528:DC%2BD3cXmtVGgsg%3D%3D 10698016 (Pubitemid 30052939)
7. J Christofides M Bridel M Egerton GM Mackay CM Forrest N Stoy, et al. 2006 Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury J Neurochem 97 4 1078 1088 10.1111/j.1471-4159.2006.03807.x 10.1111/j.1471-4159.2006.03807. x 1:CAS:528:DC%2BD28XlsVOnt7w%3D 16573644
8. W Emser M Brenner T Stober K Schimrigk 1988 Changes in nocturnal sleep in Huntington's and Parkinson's disease J Neurol 235 3 177 179 10.1007/BF00314313 10.1007/BF00314313 1:STN:280:DyaL1c3hsVChsg%3D%3D 2966851
9. Huntington Study Group 1996 Unified Huntington's disease rating scale: reliability and consistency. Huntington study group Mov Disord 11 2 136 142 10.1002/mds.870110204 10.1002/mds.870110204 (Pubitemid 26082779)
10. CB Hurelbrink SJ Lewis RA Barker 2005 The use of the Actiwatch- Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease J Neurol 252 6 642 647 10.1007/s00415-005-0709-z 10.1007/s00415-005-0709-z 15742112 (Pubitemid 40864036)
11. R Leproult A Van Onderbergen M L'hermite-Baleriaux E Van Cauter G Copinschi 2005 Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men Clin Endocrinol (Oxf) 63 3 298 304 10.1111/j.1365-2265.2005.02341.x 10.1111/j.1365-2265.2005.02341.x 1:CAS:528:DC%2BD2MXhtVyisb%2FF (Pubitemid 41233447)
12. JH Meijer WJ Rietveld 1989 Neurophysiology of the suprachiasmatic circadian pacemaker in rodents Physiol Rev 69 3 671 707 1:CAS:528: DyaL1MXlslWntL4%3D 2664825
13. TI Morgenthaler T Lee-Chiong C Alessi L Friedman RN Aurora B Boehlecke, et al. 2007 Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American academy of sleep medicine report Sleep 30 11 1445 1459 18041479 (Pubitemid 350036972)
14. AJ Morton NI Wood MH Hastings C Hurelbrink RA Barker ES Maywood 2005 Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease J Neurosci 25 1 157 163 10.1523/JNEUROSCI.3842-04.2005 10.1523/JNEUROSCI.3842-04.2005 1:CAS:528:DC%2BD2MXhtVWrsr4%3D 15634777 (Pubitemid 40110776)
15. PN Pallier ES Maywood Z Zheng JE Chesham AN Inyushkin R Dyball, et al. 2007 Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease J Neurosci 27 29 7869 7878 10.1523/JNEUROSCI.0649-07.2007 10.1523/JNEUROSCI.0649-07.2007 1:CAS:528:DC%2BD2sXos1Crt7Y%3D 17634381 (Pubitemid 47093825)
16. SR Pandi-Perumal V Srinivasan GJ Maestroni DP Cardinali B Poeggeler R Hardeland 2006 Melatonin: nature's most versatile biological signal? FEBS J 273 13 2813 2838 10.1111/j.1742-4658.2006.05322.x 10.1111/j.1742-4658.2006.05322.x 1:CAS:528:DC%2BD28XnvFaisr4%3D 16817850 (Pubitemid 43910039)
17. SR Pandi-Perumal I Trakht V Srinivasan DW Spence GJ Maestroni N Zisapel, et al. 2008 Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways Prog Neurobiol 85 3 335 353 10.1016/j.pneurobio. 2008.04.001 10.1016/j.pneurobio.2008.04.001 1:CAS:528:DC%2BD1cXosVymurY%3D 18571301
18. V Srinivasan SR Pandi-Perumal DP Cardinali B Poeggeler R Hardeland 2006 Melatonin in Alzheimer's disease and other neurodegenerative disorders Behav Brain Funct 2 15 10.1186/1744-9081-2-15 10.1186/1744-9081-2-15 1:STN:280:DC%2BD2svltlKntg%3D%3D 16674804 (Pubitemid 43994747)
19. N Stoy GM Mackay CM Forrest J Christofides M Egerton TW Stone, et al. 2005 Tryptophan metabolism and oxidative stress in patients with Huntington's disease J Neurochem 93 3 611 623 10.1111/j.1471-4159.2005.03070.x 10.1111/j.1471-4159.2005.03070.x 1:CAS:528:DC%2BD2MXktFKgtbY%3D 15836620 (Pubitemid 40617621)
20. N Taylor D Bramble 1997 Sleep disturbance and Huntingdon's disease Br J Psychiatry 171 393 10.1192/bjp.171.4.393c 10.1192/bjp.171.4.393c 1:STN:280:DyaK1c%2FktVOksg%3D%3D 9373439
21. I Tunez P Montilla MM Del Carmen M Feijoo M Salcedo 2004 Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease J Pineal Res 37 4 252 256 10.1111/j.1600-079X.2004.00163.x 10.1111/j.1600-079X.2004.00163.x 1:CAS:528:DC%2BD2cXpsFCgsr4%3D 15485551 (Pubitemid 39457046)
22. A Videnovic S Leurgans W Fan J Jaglin KM Shannon 2009 Daytime somnolence and nocturnal sleep disturbances in Huntington disease Parkinsonism Relat Disord 15 471 474 10.1016/j.parkreldis.2008.10.002 10.1016/j.parkreldis.2008.10.002 19041273
23. X Wang S Zhu Z Pei M Drozda IG Stavrovskaya SJ Del Signore, et al. 2008 Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease J Neurosci 28 38 9473 9485 10.1523/JNEUROSCI.1867-08.2008 10.1523/JNEUROSCI.1867-08.2008 1:CAS:528:DC%2BD1cXht1Sgtr3I 18799679
24. M Wiegand AA Moller CJ Lauer S Stolz W Schreiber M Dose, et al. 1991 Nocturnal sleep in Huntington's disease J Neurol 238 4 203 208 10.1007/BF00314781 10.1007/BF00314781 1:STN:280:DyaK3MznsVWrsg%3D%3D 1832711
25. N Zisapel 2001 Circadian rhythm sleep disorders: pathophysiology and potential approaches to management CNS Drugs 15 4 311 328 10.2165/00023210- 200115040-00005 10.2165/00023210-200115040-00005 1:CAS:528:DC%2BD3MXjs12nsbo%3D 11463135